01Objectives
The client had built a strong platform across multiple hospital workflows, with real traction in assets, lab operations, transfusion medicine, and supply chain.
They were entering a growth phase and needed predictable, repeatable enterprise sales cycles. The CEO set a clear goal: acquire 12 new logos with at least Phase 1 implementation at each health system.
The products delivered real outcomes, and a high-level narrative was in place. But in large health systems, growth depends on aligning multiple stakeholders: clinical, operational, financial, and technical. Instead of a unified platform story, different buyers were seeing different versions of the company across asset tracking, lab workflows, and supply chain visibility.
Each was valid, but none was complete. This fragmented perception created friction in enterprise sales, where alignment — not interest — determines deal progression.
The mandate became clear: create a unified platform story that accelerates multi-stakeholder alignment, without disrupting existing credibility.
02Challenges
The organization had strong talent, working products, and real customer proof points. The issue was how that value showed up in enterprise conversations.
Across deals, the same questions kept resurfacing. Buyers struggled to understand what the platform actually was, why it mattered at an enterprise level, and how it extended beyond a single use case. Ownership was unclear — both in terms of budget and decision-making — and different stakeholders interpreted the value differently.
Internally, this led to hesitation in how to position and sell. Externally, it slowed deal progression and made alignment among stakeholders harder.
In complex hospital environments, decisions are not made on the basis of interest alone. They require clarity across multiple functions. When that clarity is missing, deals do not stall — they quietly disappear.
03Decision
Early discussions reflected the reality of the situation: multiple valid narratives, multiple entry points into the market, and several reasonable directions the company could pursue. But none of them created a strong enough growth-forcing function.
We recommended a reset.
Before scaling sales, the organization needed to align on a simple but critical question: what are we actually selling, and why does it win at the enterprise level?
Three principles helped bring that alignment
- The platform had to create material, not incremental, value for hospitals.
- Every use case needed to reinforce a single, scalable platform narrative.
- Sales success depended on multi-stakeholder clarity, not feature depth.
This shifted the conversation from "what can we build?" to "what will customers buy, adopt, and expand?"
04Execution
Execution moved quickly with a different structure. Instead of progressing step by step, we aligned product, go-to-market, leadership messaging, and sales motion in parallel. The goal was not just to improve the story, but to make it usable in real conversations with buyers.
First, the platform was reframed.
Instead of being presented as a collection of workflows or modules, it was positioned as:
A real-time operating layer connecting physical operations to clinical and financial outcomes.
This created a stronger, more strategic anchor for all conversations.
Second, the value was clarified for each stakeholder.
Executive sponsors, economic buyers, and functional leaders were given distinct but connected narratives. Each group could see their specific problem, their metrics, and the outcomes that mattered to them. This made it easier to align CIOs, COOs, clinical leaders, and finance stakeholders around a shared view of value.
Third, enterprise sales discipline was introduced.
Every deal was anchored around three roles: a business champion, an economic buyer, and a functional owner. This helped the team identify real opportunities earlier, avoid false momentum, and move deals forward with greater confidence.
Finally, internal debate was replaced with market validation.
Instead of refining messaging in isolation, capabilities were tested directly with buyers. Objections surfaced earlier, the narrative improved faster, and confidence shifted from internal assumptions to real-world feedback.